Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laure Ricard

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Leukemia Research|June 24, 2016
Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature reviewEric Grignano, Arsene Mekinian, Thorsten Braun, et al.
Cancers|August 26, 2023
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)Marion Detroit, Mathis Collier, Nathanaël Beeker, et al.
Haematologica|May 21, 2026
Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapsePierre Sesques, Roch Houot, Yassine Al Tabaa, et al.
Nature Cancer|April 3, 2025
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA studyGuillaume Cartron, Roch Houot, Yassine Al Tabaa, et al.
Blood Cancer Journal|August 11, 2021
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignanciesFlorent Malard, Béatrice Gaugler, Joel Gozlan, et al.
Journal of Hematology & Oncology|July 3, 2026
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control armGuillaume Cartron, Isabelle Chaillol, Roch Houot, et al.
Blood Advances|October 22, 2025
Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registryFederico Erbella, Emmannuel Bachy, Guillaume Cartron, et al.
Clinical and Experimental Medicine|August 11, 2022
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseasesVincent Jachiet, Laure Ricard, Pierre Hirsch, et al.
Blood|January 7, 2022
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patientsMatthew R Wilson, Toby A Eyre, Amy A Kirkwood, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Leukemia Research|June 24, 2016
Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature reviewEric Grignano, Arsene Mekinian, Thorsten Braun, et al.
Cancers|August 26, 2023
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)Marion Detroit, Mathis Collier, Nathanaël Beeker, et al.
Haematologica|May 21, 2026
Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapsePierre Sesques, Roch Houot, Yassine Al Tabaa, et al.
Nature Cancer|April 3, 2025
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA studyGuillaume Cartron, Roch Houot, Yassine Al Tabaa, et al.
Blood Cancer Journal|August 11, 2021
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignanciesFlorent Malard, Béatrice Gaugler, Joel Gozlan, et al.
Journal of Hematology & Oncology|July 3, 2026
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control armGuillaume Cartron, Isabelle Chaillol, Roch Houot, et al.
Blood Advances|October 22, 2025
Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registryFederico Erbella, Emmannuel Bachy, Guillaume Cartron, et al.
Clinical and Experimental Medicine|August 11, 2022
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseasesVincent Jachiet, Laure Ricard, Pierre Hirsch, et al.
Blood|January 7, 2022
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patientsMatthew R Wilson, Toby A Eyre, Amy A Kirkwood, et al.
Pageof 4